Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Dimension Therapeutics, Inc. (DMTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/09/2017 |
4
| FMR LLC (See Remark 1) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Unknown transaction of 3,838,249 shares
@ $6, valued at
$23M
Unknown transaction of 1,050,016 shares
@ $6, valued at
$6.3M
Unknown transaction of 5,057 shares
@ $6, valued at
$30.3k
|
|
11/07/2017 |
4
| Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 278,035 shares
@ $0 Disposed/sold 50,000 options to buy
@ $7.14, valued at
$357k
Disposed/sold 60,000 options to buy
@ $1.9, valued at
$114k
|
|
11/07/2017 |
4
| Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 27,711 options to buy
@ $3.57, valued at
$98.9k
Disposed/sold 180,815 options to buy
@ $3.57, valued at
$645.5k
Disposed/sold 17,104 options to buy
@ $4.09, valued at
$70k
Disposed/sold 65,000 options to buy
@ $7.14, valued at
$464.1k
Disposed/sold 60,000 options to buy
@ $1.9, valued at
$114k
|
|
11/07/2017 |
4
| Morris Arlene (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
11/07/2017 |
4
| MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 55,772 options to buy
@ $4.09, valued at
$228.1k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
11/07/2017 |
4
| Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 481,696 options to buy
@ $0.56, valued at
$269.7k
Disposed/sold 74,375 options to buy
@ $3.57, valued at
$265.5k
Disposed/sold 342,113 options to buy
@ $4.09, valued at
$1.4M
Disposed/sold 160,000 options to buy
@ $7.14, valued at
$1.1M
Disposed/sold 192,000 options to buy
@ $1.9, valued at
$364.8k
Disposed/sold 150,000 options to buy
@ $1.35, valued at
$202.5k
|
|
11/07/2017 |
4
| Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 38,000 options to buy
@ $4.6, valued at
$174.8k
|
|
11/07/2017 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
11/07/2017 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
11/07/2017 |
4
| Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 128,292 options to buy
@ $0.56, valued at
$71.8k
Disposed/sold 80,396 options to buy
@ $4.09, valued at
$328.8k
Disposed/sold 50,000 options to buy
@ $7.14, valued at
$357k
Disposed/sold 50,000 options to buy
@ $1.9, valued at
$95k
|
|
11/07/2017 |
4
| Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 44,474 options to buy
@ $4.85, valued at
$215.7k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
|
|
07/05/2017 |
4
| Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 150,000 options to buy
@ $1.35, valued at
$202.5k
|
|
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2017 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
05/26/2017 |
4
| Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/03/2017 |
4
| Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 192,000 options to buy
@ $1.9, valued at
$364.8k
|
|
02/03/2017 |
4
| Wadsworth Samuel C. (Chief Scientific Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 60,000 options to buy
@ $1.9, valued at
$114k
|
|
02/03/2017 |
4
| Clark K. Reed (SVP of Pharmaceutical Develop) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $1.9, valued at
$76k
|
|
02/03/2017 |
4
| Crombez Eric (Chief Medical Officer) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.9, valued at
$95k
|
|
02/03/2017 |
4
| Franchi Jean M. (CFO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 60,000 options to buy
@ $1.9, valued at
$114k
|
|
02/03/2017 |
4
| Thistle Mary (COO) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 60,000 options to buy
@ $1.9, valued at
$114k
|
|
01/20/2017 |
4
| Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc. |
06/08/2016 |
4
| Clark K. Reed (SVP of Pharmaceutical Develop) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Sold 5,000 shares
@ $10, valued at
$50k
Exercised 5,000 options to buy
@ $0.38, valued at
$1.9k
|
|
05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/23/2016 |
4
| MIGAUSKY GEORGE V (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
05/23/2016 |
4
| Gupta Rishi (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/23/2016 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc. |
05/23/2016 |
4
| Colowick Alan (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|